Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Intellia Thera CS (NQ: NTLA ) 26.46 +1.13 (+4.46%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,816,553 Open 25.07 Bid (Size) 26.00 (5) Ask (Size) 26.68 (2) Prev. Close 25.33 Today's Range 25.07 - 26.76 52wk Range 19.37 - 43.56 Shares Outstanding 88,140,978 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 7 Biotech Stocks to Keep on Your Clinical Radar Today 14:57 EDT Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs. Via InvestorPlace 3 Gene Editing Stocks That Could Grow Your Wealth July 17, 2024 Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks. Via InvestorPlace Performance YTD -14.15% -14.15% 1 Month +5.84% +5.84% 3 Month +21.21% +21.21% 6 Month +1.26% +1.26% 1 Year -36.88% -36.88% More News Read More 3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition July 17, 2024 Via InvestorPlace Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday July 12, 2024 Via Benzinga Unveiling 6 Analyst Insights On Intellia Therapeutics June 24, 2024 Via Benzinga 3 Profitable CRISPR Stocks Earning Analysts’ Praise July 09, 2024 Via InvestorPlace The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 July 09, 2024 Via InvestorPlace The Bull Case for Intellia Therapeutics Stock Just Got Even Stronger July 09, 2024 Via The Motley Fool The 3 Best Gene Editing Stocks to Buy in July 2024 July 08, 2024 Via InvestorPlace 3 Pharma Stocks Already Ushering in the Next Biotech Boom July 08, 2024 Via InvestorPlace The 3 Best Biotech Stocks to Buy in July 2024 July 05, 2024 Via InvestorPlace Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally July 03, 2024 Via Benzinga Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today July 02, 2024 Via Benzinga 3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024 July 02, 2024 Via The Motley Fool Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet June 28, 2024 Via InvestorPlace You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever. June 27, 2024 Via InvestorPlace Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump June 26, 2024 Via Benzinga 3 Gene Editing Stocks That Could Make Your Grandchildren Rich June 25, 2024 Via InvestorPlace RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session June 24, 2024 Via Benzinga 5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More June 24, 2024 Via Benzinga Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024 June 21, 2024 Via InvestorPlace Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio? June 16, 2024 Via Benzinga Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness June 10, 2024 Via Benzinga Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought June 09, 2024 Via The Motley Fool These 2 Words Are Why Intellia Therapeutics Could Be a Smart Buy Right Now June 08, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.